December 21 (SeeNews) - Bulgarian veterinary drug maker Biovet [BUL:53B] said on Wednesday 194 shareholders, who own 207,724 of its shares among themselves, have accepted the buyout offer of majority owner Huvepharma and minority shareholder Opportunity 2009.